FDA — authorised 15 May 2018
- Application: BLA125545
- Marketing authorisation holder: HOSPIRA INC
- Local brand name: RETACRIT
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Epogen in United States
FDA authorised Epogen on 15 May 2018
Marketing authorisations
FDA
- Status: approved
Epogen in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in United States
Frequently asked questions
Is Epogen approved in United States?
Yes. FDA authorised it on 15 May 2018; FDA has authorised it.
Who is the marketing authorisation holder for Epogen in United States?
HOSPIRA INC holds the US marketing authorisation.